Food and Drug Administration
President Donald Trump’s nominee to head the Food and Drug Administration (FDA), Martin Makary, is an incredibly credentialed Harvard graduate, John Hopkins University surgeon, and bestselling author. Perhaps of greater note, he has also been unafraid to challenge healthcare establishment views on a variety of topics ranging from pricing to federal agency policy. He may […]
The fight against rare diseases has been slow due to several factors relating to regulations, something Representatives Gus Bilirakis (R-FL) and Doris Matsui (D-CA) seek to amend in recent bipartisan legislation easing the regulatory process between the Food and Drug Administration (FDA) and rare disease specialists so that treatments can be developed more efficiently. As […]
Despite the enactment of the Uyghur Forced Labor Prevention Act (UFLPA), which prohibits the importation of goods manufactured in the Xinjiang Uyghur Autonomous Region (XUAR), recent reports allege some XUAR-based pharmaceutical companies are still exporting to the US. Xinjiang Nuziline Bio-Pharmaceutical Co. and SEL Biochem Xinjiang Co are, according to the reports, rumored to use […]
As a vape store owner and operator, I was glad to see the U.S. Senate Committee on the Judiciary press top officials at the U.S. Food and Drug Administration (FDA) and Department of Justice for answers about the massive increase in illicit, unauthorized vaping sales in the United States. The federal government’s inaction and ineffectiveness has created […]
Representative Gus Bilirakis (R-FL) – a senior member of the Health Subcommittee in the U.S. House of Representatives – and Senator Rick Scott (R-FL) held a conversation with healthcare and biotech industry leaders in the Tampa Bay area to discuss the processes of the Food and Drug Administration (FDA) in hopes of facilitating “development of […]
Senate conservatives have expressed concern over potential adverse environmental impacts of increased abortion pill usage. The legislators are responding to rising rates of mifepristone use after President Joe Biden directed the Food and Drug Administration’s (FDA) deregulation of the medicine. Mifepristone, which is used with Misoprostol, accounts for half of the abortions that occur in […]
Representative Vern Buchanan’s (R-FL) Mandating Exclusive Review of Individual Treatments (MERIT) Act has passed the House Energy and Commerce Committee and will likely find its way to the House Floor. The bill is designed to “help ensure coverage of potentially life-saving drugs and new treatments for seniors with Alzheimer’s disease,” according to Rep. Buchanan’s press […]